[
    {
        "utterance": "Judith Eisen: Hello everyone. ",
        "annotations": {
            "process management": "The utterance is a greeting that serves to initiate the meeting or gather everyone's attention, which can be considered a part of managing the meeting flow or structure."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Hello. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: We are in breakout room one. Oh, which yeah, there's about B5. Do you agree with that? But B4, those are assigned actually. I know. So what I'd like you to do is just take a minute and think about causation. ",
        "annotations": {
            "process management": "Judith is managing the meeting flow by clarifying their current environment.",
            "ask question": "Judith is seeking agreement from the group.",
            "assign task": "Judith is assigning a task to the group to think about causation."
        }
    },
    {
        "utterance": "Elizabeth Bess: use that for the basis of our conversation. ",
        "annotations": {
            "clarify goal": "The utterance helps define the objective of their conversation by specifying they should use causation as the basis for their discussion.",
            "develop idea": "The utterance expands on Judith Eisen's suggestion to focus on causation by proposing it as the basis for their conversation."
        }
    },
    {
        "utterance": "Judith Eisen: fellow. And once we've done that, we need to maybe she had to choose someone or someone can volunteer to take it out and I had to come back and something I need to do whatever assignment I have to do. Okay. ",
        "annotations": {
            "process management": "Judith is managing the meeting flow by indicating what needs to be done next.",
            "assign task": "Judith is assigning or mentioning tasks that need to be done, including possibly volunteering someone for a task and referring to her own assignment."
        }
    },
    {
        "utterance": "Unidentified Speaker: Group four. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Group four. I'll put you in group four. ",
        "annotations": {
            "process management": "Judith Eisen is managing the meeting flow by assigning participants to groups.",
            "assign task": "Judith Eisen is assigning a participant to group four."
        }
    },
    {
        "utterance": "Unidentified Speaker: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay. So anyone else? ",
        "annotations": {
            "encourage participation": "The speaker is inviting others to contribute or participate by asking if there are any others.",
            "process management": "The speaker is managing the meeting flow by checking for any other groups or participants."
        }
    },
    {
        "utterance": "Judith Eisen: So Alexa, where do you want to go? ",
        "annotations": {
            "encourage participation": "The speaker, Judith Eisen, is directly asking Alexa for her input or preference on where to go, which encourages Alexa to participate in the discussion."
        }
    },
    {
        "utterance": "Unidentified Speaker: Room 22 would be great. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive sentiment towards a suggestion (Room 22 would be great)."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a brief acknowledgment without additional content."
        }
    },
    {
        "utterance": "Unidentified Speaker: develops organoid models, organ models from stem cells of the peripheral nervous system, particularly the interior nervous system and we're interested in figuring out how these different interior neurons and these organoids are affected in disease. ",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating their own area of expertise or research interest related to the task."
        }
    },
    {
        "utterance": "Unidentified Speaker: So in the gut those would be motility diseases that you know lead to abnormalities in movement of the gut tube and muscle tissue. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previously mentioned topic by providing more specific information about motility diseases and their effects, which elaborates on an existing idea."
        }
    },
    {
        "utterance": "Unidentified Speaker: We're also interested in figuring out how neurological diseases like Parkinson's and Alzheimer's and other neurodegenerative diseases manifest in the interior nervous system. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous idea about the interests of their group, specifically regarding the study of neurological diseases.",
            "clarify goal": "The utterance helps in defining what the group is interested in studying, which can be seen as clarifying their objectives."
        }
    },
    {
        "utterance": "Unidentified Speaker: Thank you. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input with a simple 'Thank you.'"
        }
    },
    {
        "utterance": "Unidentified Speaker: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: That was that was great. ",
        "annotations": {
            "Supportive response": "The utterance expresses a positive evaluation of a prior contribution, which aligns with the definition of a supportive response."
        }
    },
    {
        "utterance": "Aaron Longbrake: Hi, I'm Aaron Longbrake. I'm at Yale. I'm a neuro immunologist. My research is mainly in multiple sclerosis. Um, and I'm interested in detecting the disease before it has caused damage to the nervous system. So I'm interested in the microbiome both as something that might facilitate some of the genetic environmental interactions that lead to the immune disregulation of MS. ",
        "annotations": {
            "signal expertise": "Aaron explicitly states his own expertise or qualifications related to the task, mentioning he is a neuro immunologist and his research focus."
        }
    },
    {
        "utterance": "Aaron Longbrake: I'm also interested in in it as a biomarker of something that may be able to help us detect when something first starts to go awry that ultimately would lead to autoimmunity. Um so that's my general. ",
        "annotations": {
            "develop idea": "Aaron is expanding on his previous statement about his research interests, providing more details about his goals and objectives."
        }
    },
    {
        "utterance": "Judith Eisen: So are there any. ",
        "annotations": {
            "ask question": "Judith Eisen is requesting information or contributions from others.",
            "encourage participation": "Judith Eisen is inviting others to contribute their thoughts or ideas."
        }
    },
    {
        "utterance": "Pamela Chang: Hi, my name is Pamela Chang and I'm a professor at Cornell and Ithaca. Um my lab is interested in developing chemical tools to uh characterize or study the metabolism of the gut microbiome. ",
        "annotations": {
            "signal expertise": "Pamela explicitly states her position as a professor and her lab's focus area, which indicates her expertise."
        }
    },
    {
        "utterance": "Pamela Chang: And we also look at small molecule metabolites that bacteria in the gut make that modulate. ",
        "annotations": {
            "develop idea": "The speaker is expanding on their previous statement about their lab's interests, specifically focusing on small molecule metabolites and their modulatory effects."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Uh I think I can start sharing some of my thoughts. All right, great. To me, I think in human study, the golden standard to establish causation is to perform a randomized. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new idea about the golden standard for establishing causation in human studies, which is to perform a randomized study.",
            "develop idea": "The speaker starts to share thoughts, which could be seen as a minimal development of an idea, but it's more about introducing a concept."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: I am chemical and biological engineering at Iowa State University. Our interest is in the microbiome and ecosystem where there's a limitation that it wasn't at the level to our. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their background and field of interest, signaling their expertise or qualifications."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And we know that for some of the micro composition and also micro metabolites that are associated with different factors. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a thought related to the microbiome, specifically mentioning micro composition and micro metabolites in relation to different factors."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So in the area of neuroimmunology that came into lab with the observation that specific metabolites can actually ramp up signaling. And if we assume that we're able to find those genetic variants, I actually right now we are able to find some of those people carrying those variants they have a higher level of those micro. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by sharing specific observations and findings from their lab in the area of neuroimmunology.",
            "signal expertise": "The speaker is explicitly stating their research findings, indicating their expertise in the area of neuroimmunology and genetics."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So if that variant is increasing that micro and that variant is also increasing risk of Parkinson's, we can establish a relationship between that micro and. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the relationship between genetic variants, microbiome, and disease risk.",
            "propose new idea": "The speaker suggests a new approach to establishing a relationship between microbiome components and disease risk."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So it's a master in human genetics called randomization is basically using a variant. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on an existing idea by explaining the concept of randomization in human genetics."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And we can randomize the drug and we can also randomize variants to different and we can test if that variant is associated with a specific. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on a previously mentioned concept (establishing causation) by providing more details on how it can be applied (through randomization).",
            "signal expertise": "The speaker is demonstrating knowledge in the area of study, specifically in human genetics and microbiome research."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So that it was too long. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it does not explicitly perform any of the actions described in the codebook."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Can I just. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it is primarily a request for the floor rather than a contribution to the discussion."
        }
    },
    {
        "utterance": "Unidentified Speaker: Yes. ",
        "annotations": {
            "None": "No relevant code fully applies to this utterance as it only contains a minimal response of 'Yes.'"
        }
    },
    {
        "utterance": "Unidentified Speaker: I put on the comments box. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: The description. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Of our breakout session and I can. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Maybe start with asking. ",
        "annotations": {
            "propose new idea": "The speaker suggests a new approach for the conversation, which is to start asking.",
            "encourage participation": "The suggestion to start asking encourages others to participate in the conversation."
        }
    },
    {
        "utterance": "Lisa Ryno: Yes, I I can. ",
        "annotations": {
            "Supportive Response": "The speaker, Lisa Ryno, expresses agreement and willingness to contribute, which is a positive and supportive response to a previous statement or request.",
            "Acknowledge Contribution": "Lisa Ryno also acknowledges a request or input from another group member by agreeing to take on a task or participate."
        }
    },
    {
        "utterance": "Lisa Ryno: So our permeability changes later correlate with the gut brain axis and the the blood brain barrier and the. ",
        "annotations": {
            "develop idea": "Lisa Ryno is expanding on the discussion by relating her work on permeability changes to the gut-brain axis and the blood-brain barrier, providing a specific example of how her research correlates with key concepts in the field."
        }
    },
    {
        "utterance": "Lisa Ryno: And how they're altered during. ",
        "annotations": {
            "ask question": "This code applies because the utterance is seeking clarification or more information on how certain factors are altered during a specific condition or process."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "The utterance is too brief and does not explicitly acknowledge a contribution or engage in meaningful discussion."
        }
    },
    {
        "utterance": "Lisa Ryno: Yeah, that's fine. Um yeah, I I I'm an associate professor of chemistry biochemistry at Oberlin College, which is a small undergraduate in Ohio. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her own expertise and qualifications as an associate professor of chemistry biochemistry at Oberlin College."
        }
    },
    {
        "utterance": "Lisa Ryno: Um and my lab studies um looking for leverage points inside and outside of the bacterial cell to change biofilm composition and growth. ",
        "annotations": {
            "signal expertise": "Lisa Ryno is sharing her research focus, which indirectly signals her area of expertise in studying bacterial cells and biofilm composition and growth."
        }
    },
    {
        "utterance": "Lisa Ryno: So I'm I'm very much a reductionist and I'm thinking about the chemicals, organoids, the brain. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her approach and focus, indicating her expertise or perspective."
        }
    },
    {
        "utterance": "Lisa Ryno: And how the high level but when I was I I can expect great discussion about this. So who wants to get started? Simple, fewest variable model system in order to prove causation tends to be a reasonable. ",
        "annotations": {
            "encourage participation": "Lisa Ryno invites others to contribute by asking 'So who wants to get started?'",
            "develop idea": "Lisa Ryno suggests that a 'Simple, fewest variable model system in order to prove causation tends to be a reasonable' approach, building on previous discussion"
        }
    },
    {
        "utterance": "Judith Eisen: Maybe I should ask the next question. ",
        "annotations": {
            "process management": "Judith Eisen is managing the conversation flow by suggesting she will ask the next question.",
            "ask question": "Judith Eisen indicates her intention to seek information or clarification by asking the next question."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: bacteria that produce there's a lot of molecules all of those I don't know the changes and common to make also another small appreciate that study about so so in humans they are direct correlation so we went after some of those genetically right so you can go actually and target pathways that are indirectly actually related to barriers and that in the end if you have actually my you can affect the blood brain. ",
        "annotations": {
            "develop idea": "She is expanding on existing ideas by discussing a specific study and approach.",
            "offer feedback": "She is providing specific suggestions for how to target pathways genetically to affect the blood-brain barrier."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: everything that is in your gut what size molecules can actually get into the brain, right? Which is important as well. ",
        "annotations": {
            "ask question": "This code applies because the speaker is explicitly requesting information or clarification on the size of molecules that can move from the gut into the brain."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So I I couldn't find I couldn't find very actually. So so we had to design some systems but I'm I'm looking actually to find good in both directions and work towards the the middle or do you expect. ",
        "annotations": {
            "ask question": "Judith Eisen is seeking input from others with 'or do you expect.'",
            "develop idea": "Judith Eisen is elaborating on her approach to finding a solution or making progress in their research.",
            "clarify goal": "Judith Eisen is discussing her approach to achieving their goal, though less directly."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So if you guys because we are very you know I went along the barrier but not the blood brain barrier. So we are applying to learn about. ",
        "annotations": {
            "None": "No relevant code perfectly applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: First and then some of the more complex systems we couldn't really find the best one. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas by discussing the progression from simple to complex systems in their research approach.",
            "identify gap": "The speaker recognizes a gap in their research, specifically in finding a suitable complex system for their studies."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I think it's definitely start from both directions approaching to meet out the genetic effect. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting a method.",
            "offer feedback": "The speaker is providing a suggestion for how to proceed."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: And with the molecule needs to be appropriately sized though I mean in a sense if you have there's so many different layers or mediators that are within the blood stream they could impact the endothelium and create leakiness that would be independent of the size of the molecule because once you've broken down the barrier then large molecules can pass too. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by discussing the importance of molecule size and the role of different layers or mediators in the bloodstream.",
            "offer feedback": "The speaker provides a perspective on how different factors could impact the barrier, which can be seen as offering feedback on the discussion."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: They can but then uh the other question is you know if we're talking about the proper trigger. So sometimes when I sort of think about causation. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the 'proper trigger' related to causation.",
            "develop idea": "The speaker is expanding on his thoughts regarding causation, indicating he is building upon or elaborating existing ideas."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: So we can really come up with a system where you predict molecular causation because if you do it genetically it's not a lot it's kind of where we don't really have a if you can't predict then you can go by size some of those things will be not specific but others will be. So I don't know that's my thinking. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting an approach to predict molecular causation.",
            "critical response": "The speaker is questioning the genetic approach by highlighting its limitations and suggesting an alternative."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: To what extent do we actually have to understand those processes for us to even establish causality is the my question for me. So maybe it sort of just depends on the on the type of model we're talking about and. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on a prior statement or idea by asking about the necessity of understanding processes to establish causality."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I think it'd be nice, yeah. ",
        "annotations": {
            "None": "The utterance is too brief and does not clearly fit into another category, but it does express a positive sentiment."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So I I will I will say for from my own experience I think that can be a big issue especially. So Pamela you work with metabolites and small molecules any any thoughts about this. ",
        "annotations": {
            "ask question": "The speaker is requesting information or expertise from Pamela on a prior statement or idea proposed.",
            "encourage participation": "The speaker is inviting Pamela to contribute her expertise, opinions, or ideas."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Yeah, so we I mean in the gut we look at barrier with uh you know either two or three cells that you can give the trigger and then measure flux for different sizes. But I'm actually not familiar with the blood brain barrier either. So I'm going to look at that but I imagine it would be similar in terms of if it's a genetic defect how that affects one versus the other barrier and is there a genetic specificity where that will happen. ",
        "annotations": {
            "Develop idea": "The speaker is building upon the previous discussion about barriers and genetic defects, elaborating on their own experience with gut barriers and questioning the similarity with the blood-brain barrier.",
            "Ask question": "The speaker is seeking information or clarification about the blood-brain barrier and its similarity to the gut barrier in terms of genetic defects and specificity.",
            "Identify gap": "The speaker explicitly states their lack of familiarity with the blood-brain barrier."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I don't know. I'm putting it very complex here but uh but those are probably happening simultaneously or in some individuals one is more uh because the the gut barrier you need like uh integrity and but brain barrier. ",
        "annotations": {
            "develop idea": "She is expanding on the idea that the processes related to gut and brain barriers could be happening simultaneously or variably in individuals, building on previous discussions.",
            "ask question": "She seems to be inviting discussion or consideration of the complexities, which could be seen as implicitly asking for thoughts or opinions."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I just want to add the comment that so the blood brain barrier the focused ultrasound will cause a temporal gap in the blood brain barrier that allows the passage over kind of subjective and recently in the few human genetics and you can close it again. So so that would allow you at least isolate that barrier separate from the intestinal barrier. ",
        "annotations": {
            "Develop idea": "The speaker is expanding on existing ideas by providing specific details about a technique related to the blood-brain barrier.",
            "Offer feedback": "The speaker is providing a specific suggestion or technique for studying the barriers."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: And based on based on those they are able to find some common and and also that the metabolites detected were different and I think that's one step closer to use genetic as defect in the barrier. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous thoughts or findings, providing more detail or perspective.",
            "offer feedback": "The speaker provides a perspective that could be seen as feedback, suggesting a way forward with the genetic aspect of the barrier."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: So I've been thinking about this since last year I would attend this conference. So how how does the gut microbe to the to the you know to the mental disorder is kind of interesting but from you know perspective let's see what's interesting for me. ",
        "annotations": {
            "ask question": "The speaker requests information or clarification on the relationship between gut microbes and mental disorders."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I don't know but I ideally we are able to find genetic variance that is causing for those disease. ",
        "annotations": {
            "None": "No relevant code perfectly applies to this utterance as it stands, but it's closest to proposing a new idea or goal in a broad sense."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So with the years there was they they they are a few actually molecules that can relate to these guys and uh you know the specific alleles become very important because some of these molecules are more molecules with our I'd say rather if it's a genetic defect how that affects one versus the other barrier and is there a genetic specificity where that will happen. ",
        "annotations": {
            "develop idea": "Judith Eisen is expanding on previous ideas by discussing the relationship between molecules, alleles, and genetic defects affecting barriers.",
            "ask question": "Judith Eisen asks about genetic specificity, seeking further information or clarification."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: And so how does that how does that affect one versus the other. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on how certain factors affect one barrier versus the other, indicating a need for more details or understanding."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I don't know but I ideally we are able to find genetic variance that is causing for those disease. ",
        "annotations": {
            "clarify goal": "The speaker expresses a desired goal of finding genetic variance that causes diseases.",
            "identify gap": "The speaker implies a current lack of knowledge about genetic variances causing diseases."
        }
    },
    {
        "utterance": "Lisa Ryno- Oberlin College (she/her): I've been thinking about this since last year I would attend this conference. So how how does the gut microbe to the to the you know to the mental disorder is kind of interesting but from you know perspective let's see what's interesting for me. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the relationship between gut microbes and mental disorders."
        }
    },
    {
        "utterance": "Lisa Ryno: logical disorder sometimes the important piece of the puzzle isn't the why the causality of it but if you look at this correlation treatment seems to work sort of like what Rosie was presenting with you know those kids having major behavioral improvements. So if I can go back to the metabolites, I know that we we use losing chambers to study just physiology. So I you know, as I'm and to provide and researching fatty acids that would improve just to put the emphasis on can enable causation to in order to demonstrate that. The best one that I know of is IBD so where manipulating the microbiome in that way is a valid form of treatment and just that permeability is one of the other whether that's caused by microbiome changes is unknown at this point or is it simply that permeability is correlated with that. So now we're trying to put together genetics permeability microbiome and I don't think that's resolved right yet. But the other thing that ",
        "annotations": {
            "develop idea": "The speaker expands on existing knowledge about the microbiome, metabolites, and their impact on diseases, providing specific examples and research directions.",
            "identify gap": "The speaker acknowledges the current gaps in understanding the relationship between genetics, permeability, and the microbiome.",
            "offer feedback": "The utterance offers suggestions for approaching the study of causality, such as focusing on metabolites and fatty acids."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: I I I feel that one thing she has tried is the approachable relationship from changing microbiome to changing autism behavior. So right now she has open label study but she's moving on to randomized control trial. Although she may not figure out the mechanism but at least with her study she may be able to show that changing microbiome is able to improve the behavior. And in terms of treatment, I think that's good enough for us. We don't need to know the intermediate mechanism. All we know that if we receive that specific microbiome you're able to improve the behavior. I think that's enough for of for our application. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing more details about the study and its approach.",
            "supportive response": "The speaker is providing a positive evaluation of the approach by suggesting that it might be 'good enough' for their application.",
            "offer feedback": "The speaker provides a suggestion by implying that understanding the mechanism might not be necessary for the treatment to be effective."
        }
    },
    {
        "utterance": "Elizabeth Bess: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Leah Pyter: too because I mostly start in mice to figure out mechanisms before applying it to humans and she kind of is doing it backwards. Um because yes if you understand the mechanisms maybe you'll be able to hone in on more simple or more palatable of treatments but you know, I think I think even some treatments now are still at the FMT level without having identified, you know, what component of the FMT is actually effective. ",
        "annotations": {
            "critical response": "The speaker questions another approach to research, suggesting it is done 'backwards' by not first understanding mechanisms.",
            "offer feedback": "The speaker provides a contrasting view on research approaches, suggesting that understanding mechanisms can help in finding more targeted treatments."
        }
    },
    {
        "utterance": "Mike O'Donnell: What is the host? ",
        "annotations": {
            "ask question": "The speaker is requesting information about the term 'host', seeking clarification or understanding of a concept discussed in the meeting."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: You're right. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Mike O'Donnell: Is it is there something about like ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification, which aligns with the definition of asking a question."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: as long as they is is treating humans. the protein or carbohydrate makeup or the ability of those things. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas by highlighting the importance of certain factors (protein or carbohydrate makeup or the ability of those things) in treating humans, thus building upon existing ideas.",
            "offer feedback": "The speaker provides a consideration for how research should be approached, suggesting that as long as something is treating humans, the makeup or ability of those things is important."
        }
    },
    {
        "utterance": "Mike O'Donnell: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Leah Pyter: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So that's ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance, as it is a minimal acknowledgment without specific content that fits into one of the provided categories."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: You is it is there something about like ",
        "annotations": {
            "ask question": "The speaker is seeking clarification or information, as evidenced by the questioning nature of the utterance."
        }
    },
    {
        "utterance": "Judith Eisen: Well starting in people is hard, right? And and and maybe should get to a mechanism but you really definitely need a lot of Right, so that could be a possible explanation for what you're seeing. acids we do that for example, right? Um ",
        "annotations": {
            "develop idea": "The speaker is expanding on the challenges of research in humans and the need for understanding mechanisms.",
            "clarify goal": "The speaker is discussing the importance of understanding mechanisms in research, which relates to defining objectives."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah, I I I think you need a justification to perform a randomized control trial. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And to to do that you need evidence that you are closer to which is very important for molecular biology. ",
        "annotations": {
            "signal expertise": "The speaker explicitly mentions the importance of evidence for molecular biology, implying a level of knowledge or expertise in the field."
        }
    },
    {
        "utterance": "Judith Eisen: to group children into different subgroups? ",
        "annotations": {
            "ask question": "Judith Eisen is requesting information or clarification on how to group children into different subgroups."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah, all together we know that you can define them. So so so that's how it's very complicated. So you need to use microbiome to define those sub you know, those two different levels of the tabulation but that may mess up the clinical. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the complexity of using microbiome data, building on previous discussions.",
            "offer feedback": "The speaker provides insight into the potential complications of using microbiome data to define subgroups."
        }
    },
    {
        "utterance": "Leah Pyter: Sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: I'm going to say that the internet kicks me out and took me a lot of you able to get back in. So I hope you guys were doing great without your moderator. But I do teach about some of this stuff. So from what I've read, my understanding is that you know, it's it's at least in this country, it's a lot of the behavioral criteria and there's a way that people are evaluated by those behavioral criteria. ",
        "annotations": {
            "code name": "clarify goal",
            "explanation": "The speaker shares her understanding based on readings, which involves behavioral criteria and evaluation methods, potentially aiming to clarify research goals or expectations."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Oh I was just going to bring up a more direct interaction. ",
        "annotations": {
            "None": "The utterance does not explicitly fit into any of the provided categories but seems to be an attempt to contribute or add a point to the discussion."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So basically right now we can use those have similar effect increase permeability. So so so that's how it's very complicated. So you need to have at least three screen in the class. There's perhaps for primary subject time if you go to level then you can we we focus on one aspect for that otherwise it's very hard to address all of them. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the challenges and potential approaches in their research, building upon existing ideas.",
            "identify gap": "The speaker implies a gap in their current approach, suggesting that focusing on one aspect might be necessary due to complexity.",
            "offer feedback": "The speaker provides a suggestion for approaching the complexity of their research."
        }
    },
    {
        "utterance": "Judith Eisen: That's a good point though. Um so it sounds although going back to the original question, it sounds plausible that certain microbes um either make small metabolites that are barrier or or that's not a protease. Um so so that was something very surprising. So those also can get involved but I'm not sure at what level because there are two ways of at least two ways, right? might be can be directly through tight junction effects. ",
        "annotations": {
            "develop idea": "Judith Eisen is expanding on existing ideas by discussing the plausibility of certain microbes producing metabolites that affect barriers.",
            "supportive response": "Judith Eisen seems to be agreeing or considering the ideas presented in a positive light.",
            "offer feedback": "Judith Eisen is providing some form of feedback by discussing the implications of the ideas presented."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: I'm actually curious when when when when the team members here first chose this topic. I think one one of those is that in microbiome there was a lot of correlation specific microbes competition is associated with a specific disease. You have even diet and the microbiome there's a lot of correlation. And I think there's there's a you know, big one is that the motivation can can is good at those microbes and microbial that was my my motivation. ",
        "annotations": {
            "ask question": "The speaker directly asks how team members chose the topic, seeking information or clarification."
        }
    },
    {
        "utterance": "Elizabeth Bess: The immune cells serve as a ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So it sounds plausible that certain microbes um either make small metabolites that ",
        "annotations": {
            "develop idea": "Judith Eisen is expanding on existing ideas about microbes and their metabolites, considering their potential effects."
        }
    },
    {
        "utterance": "Judith Eisen: And from there we wanted to see how we were seeing coordination and reach among the most fine grained aspects and that's where actually all those strains was a lot of so a lot of strange things could be by their ability to damage more so there's still a lot of published so how do you to power what is the reason and that's why we were able to ",
        "annotations": {
            "develop idea": "The utterance expands on previous ideas by explaining the approach to studying microbiome interactions and their implications.",
            "summarize conversation": "The speaker is connecting previous discussions to their current research focus."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And then outside the microbiome I feel that we found actually the chance for mechanistic insight is very very high and so so anyway and that toxin is actually released and it correlates with you can add those functions that have severe disease in mice and see how those strains that produce the toxin so so it's it's minimal but have like able to mimic that or manipulate I'm looking always for ways to actually do the screening but I mean that's the major chair if you mess up if you screw any output then you actually like a research that you're driving a lot of information understanding and you lose something that might be actually there. ",
        "annotations": {
            "develop idea": "The speaker expands on an existing idea by suggesting a way to study the effect of a toxin and its correlation with disease.",
            "identify gap": "The speaker mentions the challenge of not messing up in research and potentially losing important information.",
            "offer feedback": "The speaker provides insights into research approaches and challenges."
        }
    },
    {
        "utterance": "Judith Eisen: Because most of the I mean um it's always a constant microbial genetics ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: to discover Aaron's comment on the the link via the immune system kind of brought something to mind there's been some increased interest lately in terms of the inflammatory response originating from from ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous idea or comment by mentioning an area of interest related to the immune system and inflammatory response.",
            "acknowledge contribution": "The speaker is acknowledging Aaron's comment and building upon it."
        }
    },
    {
        "utterance": "Andrew Feig: I will say ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: I'd really look at stroke models more closely if not just working on the microbiome it looks seems like a a large portion of those immune cells are coming from from the from the microbes we don't have necessary genetic tools to ",
        "annotations": {
            "propose new idea": "Judith Eisen is suggesting a new direction or approach (looking at stroke models more closely) based on the current discussion.",
            "identify gap": "Judith Eisen mentions a lack of necessary genetic tools, which can be seen as identifying a gap."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So it's very ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: something that is very open to potential either metabolites or to toxins things like that coming from from the gut and there's just some really interesting observations ",
        "annotations": {
            "develop idea": "She is expanding on existing ideas by suggesting that metabolites or toxins from the gut could be important areas of study.",
            "supportive response": "She is showing a positive attitude towards exploring these potential areas of study.",
            "offer feedback": "She is suggesting a direction for further investigation."
        }
    },
    {
        "utterance": "Andrew Feig: I'll just chime in just a second you know about regulation of IGA in the gut 12 years ago I saw the first study increase IGA production it was an animal based study the ability to impose kind of this coevolutionary idea that shifts to the benefit of the organism so if something gets across the epithelium to also be able to recognize that at the level so you could actually do respond very rapidly whether that's and plasma cells which are in the gut and the ability to add to the through a manipulation to have pretty free access to what was really astounding granted that was the antigen there that's very interesting I I looked at those what's the antigen to bring that to activate the plasma cell to express IGA or it's passing through genetic manipulation on a metabolite that's in the gut ",
        "annotations": {
            "develop idea": "The speaker is expanding on their idea about the regulation of IGA in the gut, sharing a previous study and its implications.",
            "ask question": "The speaker asks a question about the antigen and its role in activating plasma cells to express IGA, seeking more information."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: there's circulation now and on the Venus side that's where it's highly concentrated so you can have the ability to the gut and bring it up to the brain and that's where it's highly concentrated so you can have the ability to do some of the causal studies in the case of stroke at least in animals that would be a little harder to get approved in humans as well ",
        "annotations": {
            "develop idea": "The speaker is expanding on an idea related to the circulation of substances from the gut to the brain and its implications for studying stroke.",
            "identify gap": "The speaker mentions a challenge in conducting certain studies in humans, indicating a gap in current research capabilities."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah so the migration of IGA plasma from the gut going far away it's very hard to track ",
        "annotations": {
            "identify gap": "The speaker highlights the challenge of tracking the migration of IGA plasma from the gut, indicating a limitation or gap in current understanding or methodology."
        }
    },
    {
        "utterance": "Judith Eisen: I going back to to the point that you need to limit the work actually to the gut because because IGA plasma are you know just America genetic tools if you have antigen more much more ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea about limiting research to the gut and discussing the role of IGA plasma and genetic tools.",
            "clarify goal": "The utterance helps in understanding the goal or approach of limiting work to the gut."
        }
    },
    {
        "utterance": "Lisa Ryno: I was just going to say you know I think one model that is overlooked a lot one of my colleagues at University is doing for larger scale because it does have a brain access as rudimentary as it is ",
        "annotations": {
            "identify gap": "The speaker implies a gap in the current models or approaches being discussed, suggesting that her colleague's model could be relevant."
        }
    },
    {
        "utterance": "Leah Pyter: I wondered too if we're focused on ",
        "annotations": {
            "ask question": "The speaker is asking a question about the focus of their work or discussion."
        }
    },
    {
        "utterance": "Judith Eisen: I just think that's another big area of host resident microbes make just huge numbers of metabolites including pretty much all the neurotransmitters you can think of so it seems very unlikely that those neurotransmitters are going to go across the gut to the brain in the sort of quantities that you need to activate synapses but they can certainly change the overall humoral ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by providing their perspective on the role of host resident microbes in producing metabolites.",
            "offer feedback": "The speaker provides a viewpoint that could be considered feedback on the previous discussion about the potential effects of metabolites.",
            "clarify goal": "The discussion contributes to understanding the mechanisms and relationships between the gut microbiome and neurological or immunological aspects."
        }
    },
    {
        "utterance": "Leah Pyter: So I really like that immune pathway and really focus a lot on that because ",
        "annotations": {
            "Supportive response": "Leah Pyter expresses a positive sentiment towards an immune pathway, indicating her interest in focusing on it."
        }
    },
    {
        "utterance": "Judith Eisen: Like even lower than the organic level is like what's the composition how do how do those signals get to the brain ",
        "annotations": {
            "ask question": "The speaker is requesting information about the composition and how signals get to the brain, indicating a question about mechanisms.",
            "develop idea": "The speaker is building upon previous discussions about the gut-brain axis and the role of the microbiome, exploring deeper into the mechanisms."
        }
    },
    {
        "utterance": "Lisa Ryno: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: the gut has its own enteric nervous system I'm just kind of spitting out what I'm just thinking about is that the models that involve you know soluble or insoluble ",
        "annotations": {
            "propose new idea": "The utterance introduces the concept of the gut's enteric nervous system as a relevant factor in the discussion about gut-brain interactions.",
            "develop idea": "The utterance also contributes to the expansion of ideas related to how the gut and nervous system interact, by suggesting consideration of the enteric nervous system."
        }
    },
    {
        "utterance": "Lisa Ryno: I was just going to say you know I think one model that is overlooked a lot one of my colleagues at University is doing for larger scale because it does have a brain access as rudimentary as it is I guess sort of thinking about those unculturable microbes but perhaps identifying like Calvin mentions some mechanistic or more metabolites related secreted maybe the secreted proteins things that could then be back engineered into more genetically manipulable organism to help establish those ",
        "annotations": {
            "develop idea": "Lisa Ryno expands on existing ideas by suggesting a model that could help study unculturable microbes and their metabolites or secreted proteins.",
            "offer feedback": "Lisa provides a suggestion for a model and approach to studying microbes.",
            "identify gap": "Lisa implies a gap in current research regarding unculturable microbes."
        }
    },
    {
        "utterance": "Leah Pyter: I wondered too if we're focused on like plasma metabolites if we're overlooking really localized metabolites that are actually signaling to the brain neural metabolites to mention that has tons of iron transporters that that would be great if you could find that because it sucks up all of the iron ",
        "annotations": {
            "ask question": "The speaker is inquiring about the focus on plasma metabolites versus localized metabolites.",
            "develop idea": "The speaker is expanding on existing ideas by suggesting considering localized metabolites that could be signaling to the brain."
        }
    },
    {
        "utterance": "Judith Eisen: Well that's I just think that's another big area of host resident microbes make just huge numbers of metabolites including pretty much all the neurotransmitters you can think of so it seems very unlikely that those neurotransmitters are going to go across the gut to the brain ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas about the interaction between the gut microbiome and the brain, specifically discussing the potential for metabolites produced by gut microbes to influence brain function.",
            "None": "No other code seems to directly and explicitly apply beyond developing an idea."
        }
    },
    {
        "utterance": "Andrew Feig: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Like even lower than the organic level is like what's the iron composition how do how do those signals get to the brain ",
        "annotations": {
            "ask question": "The speaker is requesting information on how signals related to iron composition get to the brain.",
            "develop idea": "The speaker is building upon previous discussions about the microbiome and its connection to the brain, specifically inquiring about mechanisms at a detailed level."
        }
    },
    {
        "utterance": "Andrew Feig: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So there's direct signaling from the gut to the brain the gut has its own enteric nervous system communicated by the vagus probably also by the enteric nervous system ",
        "annotations": {
            "develop idea": "Judith Eisen is expanding on the concept of gut-brain signaling, specifically mentioning the enteric nervous system and the vagus nerve."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Oh ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So there could be neural roots particularly for the for expert there could be immune roots that things could travel so are you are you all to iron or to other inorganic molecules ",
        "annotations": {
            "develop idea": "The speaker expands on existing ideas by suggesting neural and immune roots as potential pathways for interaction.",
            "ask question": "The speaker asks for information or clarification about the involvement of iron or other inorganic molecules.",
            "encourage participation": "The speaker invites others to contribute by asking a question."
        }
    },
    {
        "utterance": "Andrew Feig: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Yeah, I find that one more feasible than like changes in rate or high enough concentration when it gets up to the brain to you know, change behavior. ",
        "annotations": {
            "code": {
                "supportive response": "Leah Pyter is showing support for a particular viewpoint by discussing the feasibility of certain mechanisms.",
                "critical response": "She is also critically evaluating the idea by comparing different mechanisms' feasibility."
            }
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: To think about if we could go back to Farouk's question like what would be a model system to figure out what seems feasible in the process and how bacteria what doesn't seem so feasible and how we could impact um just barrier function in general. ",
        "annotations": {
            "propose new idea": "The speaker suggests using a model system to study barrier function, introducing a new approach.",
            "develop idea": "The utterance builds upon previous discussion and elaborates on how to proceed with modeling.",
            "ask question": "The speaker poses a question about how to approach studying barrier function."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I'll use neurobiologist to get back to the warmth of this you could also do it with supernate and we've tried to fractionate the supernate and metabolites. ",
        "annotations": {
            "offer feedback": "The speaker provides a specific suggestion for how to proceed with research, offering an alternative approach using supernate and fractionating it.",
            "develop idea": "The speaker is building upon existing knowledge by suggesting a specific application of a method.",
            "signal expertise": "The speaker shares his experience with a specific research method, implying his expertise in the area."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: But but working with the system you know I sort of reecho this this seems like an iterative screening process where you have a model system and iteratively just screen and focus on a just general phenotype. ",
        "annotations": {
            "Develop idea": "The speaker is expanding on an existing idea by suggesting a specific methodology (iterative screening process).",
            "Offer feedback": "The speaker is providing a suggestion for how to proceed with the research.",
            "Supportive response": "The speaker is expressing validation for the approach being discussed."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So hence the idea of something like the silog where people who come from all different areas of science get together and think about questions or like that might be a mutual interest that they could approach from a lot of different directions. ",
        "annotations": {
            "propose new idea": "Judith introduces the idea of a silog for interdisciplinary collaboration.",
            "clarify goal": "Judith discusses an approach for effective collaboration across different scientific areas."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: I think that's a great question my lab's been starting to do C elegance work and that's a source of inspiration for like screening the work and like figuring it out but it's not as I have any comments thoughts um some things that we've come across working with C elegance is that it's it's it's diverse we can make mutants in low oxygen environments but how might that trigger the production of mucus. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on an existing idea or approach by sharing her lab's experience with C. elegans.",
            "identify gap": "The speaker points out a need for further investigation into how certain conditions might trigger the production of mucus."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I see so is this the is this the E letter so so is this uh we still try to figure out how to utilize that. ",
        "annotations": {
            "ask question": "Mike O'Donnell is requesting information or clarification about 'the E letter' and how to utilize it."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Um that's also a source where they're they're doing their research but for the mucus that triggers also mucus activation that's something that's that could be done there too. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges and builds upon previous contributions by mentioning another research source.",
            "develop idea": "The speaker expands the discussion by suggesting a potential research direction related to mucus and mucus activation."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I really like the studies from uh Gunar's lab so the so yeah I guess I don't I haven't worked up much with hypoxia in my case but but is there a challenge there of getting worms to survive in Gunar's hypoxic conditions or. ",
        "annotations": {
            "ask question": "The speaker is explicitly asking a question about potential challenges in working with hypoxic conditions, specifically regarding the survival of worms."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Um I think I went to one meeting that was very boring and that told shine and very important and other told. ",
        "annotations": {
            "express humor": "Elizabeth Bess makes a joke about attending a meeting that was boring, indicating humor."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: Yeah, so I I mean I'm I'm exclusively working with mucosal so so you know it's it's it's it's definitely a challenge. ",
        "annotations": {
            "signal expertise": "Mike explicitly states his current work area and focus, signaling his expertise in that area."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: So if you're interested I can send you some. ",
        "annotations": {
            "offer feedback": "The speaker is offering to provide some information or resources to the group, which can be seen as a form of feedback or additional insight."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: That's that's really low oxygen so but for humans it's kind of very tricky and I've thought about it about two to three years ago. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: So I was a PhD student in Carolyn's lab that was part of my. ",
        "annotations": {
            "signal expertise": "Elizabeth Bess is explicitly stating her own background and qualifications as a PhD student in Carolyn's lab."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: Right so so basically all the PhD I don't I don't have a good solution for that and so they are clean if you're talking about sort of lower oxygen conditions you can actually go against the wall but there are sort of there's a reason that you can use that that's where we did the sequence and that's how we found what's associated with the cause but in humans it's very hard otherwise if you go with the pro you know in the sample cleaning across the board goes after that material but in mice you can do a lot of that's that's low oxygen. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their research approach and challenges, building on existing ideas or context.",
            "identify gap": "The speaker highlights the difficulty of studying certain conditions in humans versus mice, indicating a gap in methodology or knowledge.",
            "signal expertise": "The speaker shares their expertise and experience in research, particularly in low oxygen conditions and comparative studies between mice and humans."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Well to your less specific question it's more black and white you know in our in our first blush attempts to understand something we kind of overlook the nuances you know what the nuances are and then as you start to to get down into it more you discover so do you know that there are groups so if you have a particular group for example an O that would be a substrate for a even though we know that there are things that are maybe in the context of a gut and the are so the which are maybe they're surrounded by other guys that are modulating the environment for those bacteria that are utilizing these things like breaking it down. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the research process and considerations in studying gut bacteria and their environment.",
            "identify gap": "The speaker implies that there are complexities and nuances not yet fully understood in the system being studied.",
            "clarify goal": "The speaker contributes to defining the challenges and objectives of researching complex systems like gut bacteria."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: So this is sort of maybe maybe this is sort of a big picture question that I have so so for broader identification of those things that are that are able to perform these mucal. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on a broader topic, indicating a desire to understand or explore how to identify things that can perform certain functions."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: It's very hard yeah yeah yeah but that's the that's the dream actually to do it. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive sentiment and support for pursuing a challenging goal."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Sorry, so I was a PhD student in Carolyn's lab. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: So we have about another 15 minutes and then it might be a good idea to ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by mentioning the time remaining and suggesting a next step."
        }
    },
    {
        "utterance": "Judith Eisen: Elizabeth, you're you're cutting off, would you share her screen so we can summarize highlights and see what we're going to report. ",
        "annotations": {
            "assign task": "Judith Eisen is assigning Elizabeth the task of sharing her screen.",
            "process management": "Judith Eisen is managing the meeting process by coordinating actions to summarize highlights and decide on what to report."
        }
    },
    {
        "utterance": "Elizabeth Bess: Um so I'm I'm I'm happy to let you know in like 10 or 15 minutes, but I just wanted to bring to your attention that maybe ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Oh, and another one. Um if there's something you really wanted to say and you haven't brought it up, maybe this is a good time. ",
        "annotations": {
            "encourage participation": "The speaker invites others to contribute their thoughts if they haven't already, encouraging participation.",
            "process management": "The utterance helps manage the meeting process by inviting further discussion."
        }
    },
    {
        "utterance": "Judith Eisen: I I think these are all really important points. Any other thoughts that you have maybe before we start editing the discussion? I mean, my experiences from zebrafish. I know specific cause, but I do I'm not trying to suggest that it's the be all and all in any way, but one thing that we can do is we can we can watch things and we can at least in some cases if you have how's your molecule with the right floor for or your bugs with the right floor for or cells with the right floor for for all of those things, you can actually um try to find out some of the interactions that are going on at least in the in the larvae. Um ",
        "annotations": {
            "acknowledge contribution": "The speaker is recognizing and building on the group's contributions and ideas.",
            "encourage participation": "The speaker invites others to share their thoughts before proceeding."
        }
    },
    {
        "utterance": "Judith Eisen: Um so it's they're really powerful but they're very low throughput. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno: I think it definitely goes back to what we can put organize your data about it sort of being a bidirectional process where you know we're can start start at the most reductionist molecular mechanism and that will inform higher order higher complexity experiments and then on the other end you can look at behaviors and whatever disease model you're studying and then you can go backwards from there too. ",
        "annotations": {
            "develop idea": "expanding on existing ideas through reasoning and examples for organizing research data and experiments",
            "clarify goal": "discussing objectives and success criteria for organizing experiments and data"
        }
    },
    {
        "utterance": "Lisa Ryno: It seems like in order to have a holistic picture, you have to cover all of the bases before you set it up. So the only thing we can do is potentially for tissues from ",
        "annotations": {
            "identify gap": "The speaker mentions the need to 'cover all of the bases,' implying recognizing gaps in current knowledge or approach.",
            "offer feedback": "The speaker provides a general suggestion for approaching a problem, emphasizing comprehensiveness."
        }
    },
    {
        "utterance": "Judith Eisen: I think we've we've made a lot of points and ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing the discussion by acknowledging that many points have been made."
        }
    },
    {
        "utterance": "Leah Pyter: I think even making that jump from like a germ free organism to a conventional organism that already has an ecosystem um and that you might need to use like a pre treatment like an antibiotic to really even make any sort of difference is just a hugely useful and it may not look anything like what you found in your original ways for relating that with barrier integrity to then first cast a wide net and then narrow things down for these. ",
        "annotations": {
            "develop idea": "Leah Pyter is suggesting a methodological approach of initially using a broad experimental scope before narrowing down, which aids in understanding complex systems.",
            "identify gap": "Leah Pyter implicitly identifies a gap in knowledge regarding the transition from germ-free to conventional organisms and the potential need for pre-treatments.",
            "supportive response": "Leah Pyter's utterance is supportive as she shares her perspective on experimental design in a constructive manner."
        }
    },
    {
        "utterance": "Judith Eisen: Yeah, we don't really make germ free people, although the bank of mice is is is is is I mean that's maybe as close as one gets. I mean really reliable. So ",
        "annotations": {
            "identify gap": "Judith Eisen points out a gap in research capability, specifically that germ-free humans are not created.",
            "supportive response": "Judith Eisen provides a comparison to support the discussion, suggesting mice as a reliable alternative."
        }
    },
    {
        "utterance": "Judith Eisen: I think there's more a lot of movement towards co culture systems with more engineering involved where you have small wells that are separating cells um to kind of create gut brain models that way. So I that's not something that I know much about, but that's certainly where people are going with um collaborating with engineers and think that. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: I have about two pages of notes so I can figure out how to distill this down to a few sentences. ",
        "annotations": {
            "summarize conversation": "Mike O'Donnell indicates he will summarize the discussion by condensing his two pages of notes into a few sentences."
        }
    },
    {
        "utterance": "Judith Eisen: Richard, this session's over at 11:50, is that right? ",
        "annotations": {
            "process management": "The speaker is inquiring about the end time of the session, which relates to managing the meeting flow."
        }
    },
    {
        "utterance": "Richard Wiener: Yes, I think you still have a little bit of time to to to go to another topic maybe about 11:40 you would start to kind of summarize let Mike try to to uh down a couple big points. ",
        "annotations": {
            "process management": "The utterance manages the meeting flow and timing by suggesting a transition to another topic and planning for a summary.",
            "summarize conversation": "The utterance implies summarizing the conversation by suggesting that Mike distill a couple of big points."
        }
    },
    {
        "utterance": "Judith Eisen: I I think we've we've made a lot of points and ",
        "annotations": {
            "Summarize conversation": "The speaker is summarizing the points made during the discussion.",
            "Process management": "The speaker is managing the flow of the conversation, indicating a transition or conclusion."
        }
    },
    {
        "utterance": "Elizabeth Bess: Okay, I'm just going to direct my voice right into my microphone. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: Um so I I'm wondering um you know I I there are sensors that I have been seeing that can be implanted in the brain for measuring like ",
        "annotations": {
            "ask question": "The speaker is seeking information about sensors that can be implanted in the brain."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Hi, I I have been I was listening and um you know, mainly because my expertise is not really in biology side. I'm a device person and a person who develops biosensors. So basically tools for measurement but not optical. So electronic, electrochemical sensors, um nano devices, a small, you know, sensors basically. And you know, we have been working on, you know, we work on small molecules from or or RNS and neurochemicals and also to more pathogen bacteria. Uh we have been looking at its antibiotic response using these sensors as we basically develop. So we use a lot of nanotechnology, nano materials, ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their own expertise and qualifications related to developing biosensors, which is relevant to the discussion."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Um what are your you know, wish list for example, like in these individual topics that you mentioned, you know, what are ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification from other team members on a prior statement or idea proposed."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh looks like sensors, sorry, you know, my lack of knowledge in this area, but um what do you like to or what what would be beyond the traditional standard for characterization. ",
        "annotations": {
            "ask question": "Request information, clarification, or expertise from other team members on a prior statement or idea proposed."
        }
    },
    {
        "utterance": "Elizabeth Bess: There are sensors that I have been seeing that can be implanted in the brain for measuring like neurotransmitter production etc. being able to measure and talk about if they're really correlated that undergo enterohepatic recycling or produced in the GI tract even if it's small. There was a fair amount of discussion about the various pieces of things that could be impactful and direct versus indirect effects. So ",
        "annotations": {
            "propose new idea": "Elizabeth Bess introduces the idea of using sensors that can be implanted in the brain for measuring neurotransmitter production.",
            "develop idea": "She elaborates on the potential of these sensors to measure correlations between neurotransmitter production and substances produced in the GI tract.",
            "supportive response": "The tone is informative and positive, contributing to the discussion."
        }
    },
    {
        "utterance": "Elizabeth Bess: Okay, I'm ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: That's really uh you know, that that's a great you know, point that you mentioned. So it's really like a uh very big wish um dream I would say there are a lot of ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input without adding new content or agreeing."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Like you may have heard about like smart capsule or smart pills. Uh there has been it it has been like you know, going around for a long time really like a dream that people want to have something ",
        "annotations": {
            "propose new idea": "The speaker introduces the concepts of 'smart capsule' or 'smart pills' as potential solutions or ideas.",
            "identify gap": "The speaker mentions a 'dream that people want to have something,' implying a gap between current capabilities and desired advancements."
        }
    },
    {
        "utterance": "Aida Ebrahimi: And then it can monitor and screen uh not just collect not just collect because there are capsules that you know you can eat them then um the prototype is uh they are going to uh capture uh like bacteria for example into a small polymer based capsule with hydrogel and stuff then when it is excreted by body, you know, you can take it out and then do the analysis, you know? ",
        "annotations": {
            "develop idea": "The speaker is elaborating on a specific technological concept, providing details about its functionality and application.",
            "signal expertise": "The speaker is showing familiarity with a specific technology, discussing its capabilities and design."
        }
    },
    {
        "utterance": "Aida Ebrahimi: I'm talking about something else like real time as you mentioned like real time something that goes through and then it scans for different uh ",
        "annotations": {
            "develop idea": "The speaker is trying to clarify or specify what they mean by real-time monitoring or scanning, building on previous discussion.",
            "identify gap": "The speaker implies a need for technology that can scan in real-time, suggesting a gap in current capabilities."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: I I agree with Elizabeth. ",
        "annotations": {
            "supportive response": "Judith Eisen is expressing agreement with Elizabeth Bess's statement, showing a positive evaluation of her contribution."
        }
    },
    {
        "utterance": "Judith Eisen: I think this would be a game changer. ",
        "annotations": {
            "Supportive response": "Judith is expressing a positive evaluation of an idea discussed, indicating it would be a 'game changer'."
        }
    },
    {
        "utterance": "Judith Eisen: is about to have real time monitoring of the brain or whatever else it is that you want to monitor. I mean and you can imagine, I mean my dream, we talked about it in that earlier icebreaker session is that you can you can monitor all the different things you want to monitor at once. Of course that's probably being really greedy and you know we have to back off a little bit. But even the case that you brought up Elizabeth of a metabolite, if you could monitor that metabolite and who's who's eating it and what they're turning it into, so the life of that metabolite in the gut as it does whatever else it does in the body that would be something in the brain would be amazing. ",
        "annotations": {
            "develop idea": "She is expanding on previous ideas about monitoring and its applications.",
            "supportive response": "She is expressing a positive view towards the concept of real-time monitoring.",
            "clarify goal": "She is discussing the aspirations and goals of their research in terms of monitoring capabilities."
        }
    },
    {
        "utterance": "Judith Eisen: And then if you start thinking about causation versus correlation, it really starts to get you to the biochemistry of of those processes and then you have you know actual biochemical testing that you could do to to ask whether your inferences are are correct and whether if you play with this thing in some particular way, you can change a different process. ",
        "annotations": {
            "develop idea": "The utterance expands on existing ideas by discussing the necessity of biochemical testing to understand processes.",
            "supportive response": "It expresses a positive view towards considering biochemical testing.",
            "offer feedback": "Judith provides a perspective on approaching the study."
        }
    },
    {
        "utterance": "Judith Eisen: That would be amazing. Figure out if I'm missing something or if there's better ways to do it. Aida make these for us. ",
        "annotations": {
            "supportive response": "Expressing agreement or positive evaluation for the idea discussed.",
            "ask question": "Requesting information or alternatives to the current approach.",
            "assign task": "Directing Aida to develop or provide something."
        }
    },
    {
        "utterance": "Aida Ebrahimi: I have another question like, what is the correlation between gut microbiome and like oral cavity microbiome like mouth microbiome? What is the correlation? The reason I'm asking it is because screening like saliva for example or breath it's it's easier to actually going down in the in the gut, you know? So I was wondering is there any study or like solid evidence or not even that solid, I don't know what the word is between correlation of gut and like you know the microbiome that we have for example or similarly microbiome in our mouth and brain. ",
        "annotations": {
            "ask question": "Aida Ebrahimi is requesting information or clarification on the correlation between gut microbiome and oral cavity microbiome, indicating she is seeking existing knowledge or studies on this topic."
        }
    },
    {
        "utterance": "Judith Eisen: So there's been there's been work on this. So the human microbiome project um looked at the oral microbiome, the gut microbiome, the genital microbiome, the skin microbiome. I think they were seven different places. I don't remember what they all are. And you're right there's there's actual published data on the stuff in your mouth is linearly proportional. There are some lower throughput methods that might be useful for aerobic and anaerobic stuff to test specific hypothesis, but we need to get there. We need to know which specific hypothesis that we want to be testing on. ",
        "annotations": {
            "summarize conversation": "Judith Eisen summarizes the human microbiome project's scope, including the study of oral, gut, genital, and skin microbiomes, and discusses the need for specific hypotheses testing."
        }
    },
    {
        "utterance": "Judith Eisen: What do you guys think? So and there's a lot of differences which is not to say that there aren't some commonalities. Feel free to correct that or add something else. I'm just trying to get other people help bearing. The point that you brought up about microbiome is an interesting one because the brain is thought to be sterile, no bugs in there unless you get a breach of the blood brain barrier. ",
        "annotations": {
            "encourage participation": "The speaker invites others to contribute their thoughts or corrections.",
            "supportive response": "The speaker is acknowledging and building upon previous discussions.",
            "summarize conversation": "The speaker is summarizing aspects of the discussion to find common ground."
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah, I have it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay, thanks. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: about four or five years ago there was a paper that was published where at the EM level somebody saw bacteria. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: I know I know someone at ASU that got that last year by the way. ",
        "annotations": {
            "signal expertise": "Elizabeth Bess is indicating her connection to someone at ASU who achieved something relevant to the discussion, thereby signaling her own expertise or familiarity with the topic."
        }
    },
    {
        "utterance": "Judith Eisen: Oh really? What we want to say. There was a study that made it clear that wash at the EM level somebody saw bacteria. So I'm trying to look for follow up work. There's been enough in that time. ",
        "annotations": {
            "ask question": "Judith Eisen is seeking more information about follow-up work on a study, indicating she is requesting information or clarification.",
            "identify gap": "Judith implies there's a need for more recent follow-up work, indicating a gap in current knowledge."
        }
    },
    {
        "utterance": "Mike O'Donnell: Do you think that okay so if you go to NIH with this idea and if you're talking about high throughput high throughput screens immediately the reviewer says this is fishing expedition, this is hypothesis generating. ",
        "annotations": {
            "ask question": "The speaker is asking for opinions or thoughts on the matter.",
            "critical response": "The speaker is voicing a concern or critique about the potential reception of a research approach.",
            "offer feedback": "The speaker is providing a potential critique or concern."
        }
    },
    {
        "utterance": "Judith Eisen: certainly there are cases where people you know have has not been convinced that the gut microbiome is involved. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Can you do that? ",
        "annotations": {
            "Ask Question": "The utterance is a question seeking information or clarification about the feasibility of an action or experiment."
        }
    },
    {
        "utterance": "Mike O'Donnell: Uh yeah, I have it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: So so those are the mechanisms here, yeah. One one comment that I want to make especially to junior faculty is that not funded by NIH does not mean that it's not good research and it doesn't mean that it's not promising research indeed. And NIH chose not to fund um the production of insulin through genetic engineering the way it's done. ",
        "annotations": {
            "encourage participation": "The speaker directly addresses and encourages junior faculty, inviting them to consider funding implications.",
            "supportive response": "The speaker offers a supportive comment to junior faculty, validating their research regardless of NIH funding."
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah. ",
        "annotations": {
            "None": "No relevant code explicitly applies to this minimal utterance, but it serves as an acknowledgment."
        }
    },
    {
        "utterance": "Judith Eisen: Oh yes, there we go. ",
        "annotations": {
            "acknowledge contribution": "Judith Eisen acknowledges a prior statement or contribution."
        }
    },
    {
        "utterance": "Mike O'Donnell: I'll just blow that's really small. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Anyway, so so those are the mechanisms here, yeah. And one one comment that I want to make especially to junior faculty is that not funded by NIH does not mean that it's not good research and it doesn't mean that it's not promising research indeed. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and support for junior faculty, validating their research regardless of NIH funding."
        }
    },
    {
        "utterance": "Aida Ebrahimi: That was a great point. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and validation for another group member's contribution."
        }
    },
    {
        "utterance": "Mike O'Donnell: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: It does. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges a previous statement.",
            "supportive response": "The speaker expresses agreement or validation."
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Okay. ",
        "annotations": {
            "supportive response": "The utterance 'Okay' serves as a minimal agreement or acknowledgment, which can be considered a supportive response as it does not contradict or criticize previous statements but rather shows acceptance."
        }
    },
    {
        "utterance": "Lisa Ryno: Thank you. ",
        "annotations": {
            "acknowledge contribution": "Lisa Ryno verbally recognizes Judith Eisen's input."
        }
    },
    {
        "utterance": "Mike O'Donnell: You're welcome. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Thank you. ",
        "annotations": {
            "acknowledge contribution": "The speaker is verbally recognizing someone's input or contribution."
        }
    },
    {
        "utterance": "Mike O'Donnell: You're welcome. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So I I confess I wasn't invited to be part of the U panel last year but I wasn't so I wish I had been there so I could give you an answer of like what the panel was actually looking for. We didn't get a lot of feedback either so that's but but you know those are kind of pain questions that you can provide that on your surveys as a community that might be helpful to get some feedback on your proposals. ",
        "annotations": {
            "process management": "The speaker suggests a method to improve the process of gathering feedback on proposals.",
            "clarify goal": "The speaker implies that a goal is to enhance the feedback process for proposals."
        }
    },
    {
        "utterance": "Mike O'Donnell: I guess I have a question. ",
        "annotations": {
            "ask question": "The speaker, Mike O'Donnell, explicitly states that he has a question, which is a request for information or clarification."
        }
    },
    {
        "utterance": "Judith Eisen: I mean aside from Sialog. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: So I guess what I'm asking is that if you know it's a good idea, pursue it through other ways or pursue getting preliminary data so you can show that when I each that's that's my advice here, you know, my mentoring advice. ",
        "annotations": {
            "Signal expertise": "The speaker is sharing his advice, implying his expertise in the area.",
            "Supportive response": "The utterance offers support through advice.",
            "Offer feedback": "The utterance provides guidance or feedback."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Are there other. ",
        "annotations": {
            "ask question": "The utterance is a question seeking additional information."
        }
    },
    {
        "utterance": "Lisa Ryno: Sorry, this is getting off topic. ",
        "annotations": {
            "process management": "The speaker is trying to manage the conversation flow by suggesting that the discussion is getting off topic."
        }
    },
    {
        "utterance": "Judith Eisen: But other other places that would be in pretty good categories. So I guess we should add more details if we want to, but what do other people think? ",
        "annotations": {
            "encourage participation": "The speaker is inviting others to contribute their thoughts or opinions."
        }
    },
    {
        "utterance": "Elizabeth Bess: Come up. ",
        "annotations": {
            "encourage participation": "inviting others to contribute their expertise, opinions, or ideas."
        }
    },
    {
        "utterance": "Elizabeth Bess: Is is that a. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: Yeah, absolutely. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Mike O'Donnell: That wasn't a derisive laugh that was. ",
        "annotations": {
            "express humor": "Mike O'Donnell is making a light comment to clarify the tone of his previous laugh."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement, validating the contribution without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The utterance 'Exactly. ' expresses agreement with a prior statement, validating or positively evaluating it without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "Expressing agreement, validation, or positive evaluation for other group members' contributions without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or confirmation with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement or validation with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement, which is a form of supportive response."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement, which is a form of supportive response."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement with a previous statement, providing a positive evaluation without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The utterance 'Exactly.' expresses agreement or validation for a prior statement, making it a supportive response."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: You're absolutely right and I feel that and the co professor, I don't know that is the right professor. Like I agree with this, you know. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and support for a previous statement.",
            "identify gap": "The speaker mentions uncertainty about the term 'co professor', indicating a gap in her knowledge."
        }
    },
    {
        "utterance": "Leah Pyter, OSU (she/her): May I agree with what you're saying is what you're saying encapsulates microbial non microbial. I mean the institution I'm right now they are very supportive to that one. I think that's a fair I was in another institution and I wrote a grant that was like 5% and they were like 45% to pay to the institution. Yeah, so it depends on the institution. ",
        "annotations": {
            "Supportive Response": "Leah Pyter is expressing agreement with what someone else said."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I always like to think about these things foundations are really good and if you guys can get something from the social dialogue that might so you know you wanted to over expression and you want to do knock out. You want to move something and meeting people who do that something you want to remove something people on my end of the channel does the opposite of what I'm. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their view of how research or scientific dialogue works.",
            "encourage participation": "Judith Eisen is encouraging engagement with different perspectives or tools.",
            "supportive response": "The tone is supportive and encouraging, suggesting that engaging with different perspectives is beneficial."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Hey guys happy with her report. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: You know what you've moved. Sorry Aaron. ",
        "annotations": {
            "process management": "Judith Eisen is commenting on a change that has occurred during the meeting, possibly referring to someone changing a screen or presentation, which relates to managing the meeting flow."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: Yeah amazing. Thanks a lot for doing that. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement and thanks, positively evaluating the previous contribution without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Let's go back to that for two minutes to make sure this isn't just making stuff up. ",
        "annotations": {
            "process management": "Judith Eisen is managing the discussion flow by suggesting a revisit to a previous point to ensure accuracy."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Microbial metabolites, but there are epithelial cell metabolites, but there's got to be cell metabolites. Can you pull back the can then can then move directly or you want you want it there. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by mentioning different kinds of metabolites.",
            "ask question": "The speaker asks for clarification or an opinion regarding moving directly or if someone wants something a certain way."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): What do you want it? You want it over there? ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I mean there's a there's a a huge amount of complexity. So I think. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): I'm asking you if you want it if it was there on purpose. ",
        "annotations": {
            "ask question": "The speaker is requesting clarification or information about the intention behind something."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: You know, I mean it was supposed to be a bullet point under the one above but it didn't format it the way I thought it was going to. Somebody who's neurotypical and put it in somebody with autism and you change their behavior. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Is there anything additionally that I neglected to put on here? ",
        "annotations": {
            "ask question": "The speaker is requesting information about potential additional items that might have been neglected."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Does does not show we mentioned at some point. I don't see it anywhere. ",
        "annotations": {
            "ask question": "Judith Eisen is seeking information or clarification about something previously discussed, indicating she is asking a question."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): We did. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: You know, I don't know if we want to call it out or not. In in my perspective doing that experiment then gives you the hypothesis that you can start testing. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the thought process related to experiments and hypothesis testing.",
            "offer feedback": "The speaker provides a perspective on the scientific method, which can be seen as offering feedback on how to approach research."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Yeah, there you go. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges a previous statement or contribution.",
            "supportive response": "The utterance expresses agreement or positive evaluation."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Well people generally feel that way or if you guys are happy with that we can go back to the funding discussion which is probably more high yield anyway. ",
        "annotations": {
            "process management": "The speaker is managing the discussion flow by suggesting a shift in topics."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: We have a couple minutes left so. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by indicating the time left."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: What what do you think are? ",
        "annotations": {
            "code name": "ask question",
            "explanation": "The speaker is requesting information or opinions from others, which aligns with the definition of asking a question."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Are you guys okay with that? Are you all okay with that? ",
        "annotations": {
            "ask question": "Lisa Ryno is requesting confirmation or agreement from the group on a previous point.",
            "encourage participation": "Lisa Ryno is inviting group members to express their opinions or agreement."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): I was sort of you know thinking about I'm sorry I didn't mean to like to but they were I was just trying to ensure and help tell other No, it was a high yield discussion and one that is definitely valuable. I just wanted to before we dumped out make sure that I was appropriately group centered on what I was reporting back. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement and positive evaluation of the discussion.",
            "process management": "The speaker ensures her report is group-centered before moving on."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Thank you. ",
        "annotations": {
            "None": "The utterance is a simple expression of gratitude and does not explicitly reflect any of the defined codes."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: But I have to say in the microbiome field. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: In the early days students in my lab this is a field that has research based and there's a bias towards hypothesis. I don't fully buy into this hypothesis generated research. ",
        "annotations": {
            "signal expertise": "Judith implies her experience and familiarity with research methodologies.",
            "critical response": "Judith expresses a critical view of hypothesis-generated research.",
            "offer feedback": "Judith provides her perspective on research approaches."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): There's so much that we don't know you have to do observations before you can generate a hypothesis. So who's going to fund the observations? ",
        "annotations": {
            "identify gap": "The speaker recognizes a gap in funding for observations necessary for generating hypotheses.",
            "critical response": "The speaker questions who will fund observations, implying criticism of current research funding practices."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: The way it's portrayed which in I mean it just seems ridiculous and and barrier and I don't know at least at my institution there's a fair amount of. ",
        "annotations": {
            "Critical response": "The speaker is questioning and providing a negative evaluation of the current portrayal of research funding, suggesting it seems 'ridiculous'."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Snobbery. ",
        "annotations": {
            "critical response": "Lisa Ryno's comment implies a negative evaluation of the attitudes or biases in the research community towards funding for hypothesis-generating research."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: And it's easy way to see it portrayed and I have a fair amount of funding right now which is good for me but doesn't have the same cachet for promotion and tenure. Makes some people not think it's deeply enough. ",
        "annotations": {
            "critical response": "The speaker is questioning the value or perception of certain types of research funding in the context of career advancement.",
            "None": "No other code directly applies beyond critical response."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): That's a thing that for promotion and tenure you have an R1. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it seems to be a general comment on academic culture and not directly related to the scientific discussion or meeting management."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: And it's how you would actually get it causation versus correlation which is where we started. ",
        "annotations": {
            "summarize conversation": "The speaker is referencing and summarizing the discussion thread that started with the topic of causation versus correlation."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Maybe shouldn't. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: We're about we're about to be kicked out. I think they want to say something before. ",
        "annotations": {
            "Process management": "Mike is commenting on the session's timing, indicating they are about to be kicked out and suggesting there might be a final comment before it ends."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Does anybody have any any closing thoughts? I'm sorry I got things wrong so don't have to take. No this has been great. ",
        "annotations": {
            "process management": "Judith Eisen is managing the meeting flow by checking for final thoughts and bringing the discussion to a close.",
            "encourage participation": "Judith Eisen invites others to contribute their final thoughts, encouraging participation."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I think what you just said sounded great. That was a great discussion. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and appreciation for the previous discussion, providing a positive evaluation."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Thanks for the discussion. ",
        "annotations": {
            "supportive response": "The speaker is expressing gratitude and a positive sentiment towards the discussion that has taken place."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Thank you. ",
        "annotations": {
            "acknowledge contribution": "The speaker is thanking another group member, acknowledging their input."
        }
    },
    {
        "utterance": "Aida Ebrahimi, Penn State (she/her): Thanks for recording. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Great job. Thank you. I'm sorry I got kicked out. ",
        "annotations": {
            "supportive response": "The speaker is expressing appreciation and gratitude."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I thought this was I thought this was really interesting. You were you were back fast. It's good. time is just wonderful so thanks very much. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and positive sentiments towards the discussion, indicating a supportive response."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Very interesting perspectives on it. On the NIH keep on pursuing it and talk to program directors that's my advice because I I actually have to R1s funded and it wouldn't have happened if I hadn't talked to program directors and pursuing it and. ",
        "annotations": {
            "Supportive response": "She is offering encouragement and sharing her experience to help others.",
            "Encourage participation": "By advising to keep pursuing funding and to talk to program directors, she is encouraging active participation in the funding process.",
            "Signal expertise": "She is signaling her expertise through her mention of having R1s funded."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Piki. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Yeah honorary member of the group. ",
        "annotations": {
            "express humor": "The speaker is making a joke about being an honorary member of the group, indicating a lighthearted and humorous tone."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Very nice calm to me. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance"
        }
    }
]